Skip to main content
. 2022 Aug 31;22:219. doi: 10.1186/s12902-022-01133-0

Table 5.

Multivariate analysis for the associated factors of the non-adherence to medications

Variables Non-adherence 95%CI P-value
N % OR Lower upper
Sex
 Male 47 43.93 1 0.002**
 Female 60 56.07 2.1 1.13 3.71
Duration of diabetes
 1-3 years 49 45.79 1 0.042*
 4-10yrs 26 24.3 2.57 1.04 6.37 0.023*
 More than 10 years 32 29.91 1.03 0.34 3.12 0.031*
Education
 No formal education 17 15.89 1 0.002*
 Primary 51 47.66 3.56 1.12 11.28 0.031*
 Secondary 39 36.45 2.96 1.11 7.87 0.030*
DPCS
 Good communication 37 34.58 1 0.046*
 Poor communication 70 65.42 2.18 1.01 4.68
Employment status
 Jobless 28 26.17 1 0.061
 Public employee 28 26.17 2.01 0.92 4.38 0.08
 Private 51 47.66 1.06 0.38 2.97 0.906
Residence
 Kigali 76 71.03 1 0.089
 Out of Kigali 31 28.97 2.19 0.89 5.39
Attitudes of the family members towards patients with T2DM
 Very concerned 46 42.99 1 0.031*
 Not concerned 37 34.58 0.1.5 0.4 5.5 0.54
 Perceived as burdensome 24 22.43 5.8 1.3 25.7 0.021*
BMI
 Underweight (< 18.5 kg/m2) 10 9.35 1 0.003**
 Normal (18.5 kg/m2-24 kg/m2) 32 29.91 5.17 1.63 16.37 0.005*
 Overweight/obese (more than 24) 65 60.75 3.6 1.04 9.1 0.02*
Anti-diabetic medication
 Single OHA 59 55.14 1 0.011*
 OHA and Insulin 29 27.1 0.59 0.24 1.42 0.023*
 Insulin alone 19 17.76 0.26 0.09 0.74 0.011*
Glycosylated Hemoglobin (HbA1C)
 Good (= < 7) 20 18.69 1 0.002**
 Poor (> 7) 87 81.31 4.26 1.7 10.69
Glycaemia (in g/dl)
 Less than 170 g/dl 11 10.28 1 0.0456*
 170–250 g/dl 28 26.17 3.17 1.06 9.5 0.04*
 More than250 g/dl 68 63.55 0.8 0.33 1.97 0.626
Presence of diabetes complications
Retinopathy complication
  Yes 48 44.86 1 0.325
  No 59 55.14 1.43 0.7 2.9
Skin infections
  Yes 71 66.36 1 0.009**
  No 36 33.64 0.36 0.17 0.77

N Frequency, % Percentage, OR Odds ratio, CI Confidence Intervals, OHA Oral Hypoglycemic Agents, DPCS Doctor- Patient Communication Scale, BMI Body Mass Index, HbA1C Glycosylated Hemoglobin, rwf Rwandan francs

*p < 0.05

**p < 0.01

***p < 0.001